- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02306551
Well Being And Resilience: Mechanisms of Transmission of Health and Risk (WARM)
January 20, 2023 updated by: Susanne Harder
Well Being And Resilience: Mechanisms of Transmission of Health and Risk in Parents With Complex Mental Health Problems and Their Offspring
The purpose of this study is to establish a cohort of pregnant women with severe mental disorder and to identify biological and psycho-social transmission mechanisms involved in the development of 'risk' and 'resilience' in the offspring.
It is assumed that both 'resilient' and 'risk' development in offspring are caused by a complex interaction between multiple biological, psychological and social factors.
The project focuses specifically on exploring the impact of physiological stress-sensitivity, attachment, care-giving and the familial and social context for care-giving.
Previous studies support these factors as important for the development of these infants, but systematic research using a prospective design is needed to strengthen evidence and elucidate the importance of these factors in more detail.
The interaction over time of physiological stress-sensitivity, attachment, care-giving and the familial and social context for care-giving are evaluated in terms of the evolution of very early indicators of developmental risk and resilience in infants with a known highly increased risk for developing a mental disorder.The findings of the study may potentially lead to more specific targets for preventive interventions, which can improve developmental outcome for these infants.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
93
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Odense, Denmark, 5000
- Department of child and adolescent mental health Odense, Research Unit, Mental Health Services in the Region of Southern Denmark
-
Roskilde, Denmark, 4000
- Psychiatric Research Unit, Psychiatry, Region Sealand, Institute of Clinical Medicin, Faculty of Health Sciences, University of Copenhagen
-
-
-
-
-
Glasgow, United Kingdom
- Institute of Health and Well being, University of Glasgow
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Pregnant women referred to maternity services or psychiatric services in Denmark in Region Zealand and Region Southern Denmark, in Scotland from NHS Greater Glasgow and Clyde
Description
Inclusion Criteria:
- Pregnant women with Psychotic Disorder (DSM-5: Delusional Disorder (297.1)
- Schizophreniform Disorder (295.4), Schizophrenia (295.90), Schizoaffective Disorder (295.70)
- Brief Psychotic Disorder (298.8) Other specified schizophrenia spectrum and other psychotic disorder (298.8), Unspecified schizophrenia spectrum and other psychotic disorder (298.9) )
- Lifetime diagnosis of DSM-5 Bipolar I and II Disorder (296.89)
- Diagnosis of DSM-5 Major Depressive Disorder current single episode (current 296.22 - 296.25) or recurrent episode (296.32 - 296.35)
- Non-psychiatric control group defined as mothers without any history of treatment or admission for a psychiatric disorder or drug or alcohol addiction.
- Partners of participating women with an expected care-giving role in relation to the infant will also be eligible for participation in the study.
- Infants of participating pregnant women will be included from birth.
Exclusion Criteria:
- Unable to provide informed consent to participate
- Unable to speak English or Danish because of the requirement to complete assessments,
- Miscarriage.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Psychotic Disorder
Biological and psycho-social risk and resilience factors
|
Naturalistic study, no active intervention or exposure is administered
|
|
Bipolar Disorder
Biological and psycho-social risk and resilience factors
|
Naturalistic study, no active intervention or exposure is administered
|
|
Depressive Disorder
Biological and psycho-social risk and resilience factors
|
Naturalistic study, no active intervention or exposure is administered
|
|
Non-psychiatric Control
Biological and psycho-social risk and resilience factors
|
Naturalistic study, no active intervention or exposure is administered
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infant attachment as measured by Strange Situation Procedure (Ainsworth et al. 1978)
Time Frame: At infant 52 weeks of age
|
Strange Situation Procedure is a structured observation.
The infant is videotaped in a playroom during a series of eight structured 3-min episodes involving the baby, the mother, and a female stranger.
During the observation the mother leaves and rejoins the infant twice, first leaving the infant with the female stranger, then leaving the infant alone to be rejoined by the stranger.
The procedure is designed to be mildly stressful in order to increase the intensity of activation of the infant's attachment behavior.
Videotapes are coded for four attachment classifications: secure, avoidant, ambivalent-resistant/dependent and disorganised.
|
At infant 52 weeks of age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infant neurobehavioral outcome as measured by Neonatal Intensive Care Unit Neurobehavioral Scale, NNNS, (Lester & Tronick, 2005)
Time Frame: 1-7 days and 4 weeks
|
NNNS is a 30-minute, 128-item assessment of neurologic, behavioural, and stress/abstinence signs that evaluates the full range of infant neurobehavior.
It has 12 summary scales: habituation, attention, arousal, regulation, number of handling procedures, quality of movement, excitability, lethargy, number of non-optimal reflexes, number of asymmetric reflexes, hypertonicity, and hypotonicity and an additional stress/abstinence scale.
|
1-7 days and 4 weeks
|
|
Infant development as measured by Bayley's scales for infant development 3rd edition (BSID-III-R, Bayley, 2006)
Time Frame: 16 and 52 weeks of infant age
|
The BSID III-R is a structured observation test assessing cognition, language and motor skills.
|
16 and 52 weeks of infant age
|
|
Infant stress exposure and physiological stress-sensitivity as measured by hair and salivary cortisol
Time Frame: 1-7 days (hair only) 4 (Saliva only), 16 and 52 weeks of infant age
|
Saliva samples are collected before and 20 and 40 minutes after NNNS (4 weeks), still-face procedure (16 weeks) and Strange Situation Procedure (52 weeks)
|
1-7 days (hair only) 4 (Saliva only), 16 and 52 weeks of infant age
|
|
Infant social-interactive behavior as measured by Coding Interactive Behavior, CIB (Ruth Feldman, 2012)
Time Frame: 1-7 days, 4 and 16 weeks
|
CIB is a global measure that looks at parent-child and dyadic affective states and interactive styles.
Independent behavioral codes are aggregated into eight higher order constructs: The three child constructs are engagement involvement, withdrawal, and compliance; and the two dyadic constructs are dyadic reciprocity and dyadic negative states.
|
1-7 days, 4 and 16 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal symptom severity as measured by Positive and Negative Syndrome Scale, PANSS, Kay et al.1989, The Montgomery Asberg Depression Rating Scale, MADRS, Montgomery and Asberg, 1979. The Bech-Rafaelsen Mania Rating Scale, BRMRS, Bech et al. 1979.
Time Frame: at baseline before birth of the child and at 1-7 days, 4, 16 and 52 weeks of infant age.
|
PANSS, MADRS and BRMRS are rating scales based on a semistructured interview.
PANSS 5-factor model assesses the presence or absence of positive, negative, disorganisation, excitement and emotional distress symptoms (van der Gaag et al., 2006).
MADRS assesses the presence and severity of 10 core symptoms of depression.
BRMRS assesses the presence and severity of 11 core symptoms of hypomania/mania
|
at baseline before birth of the child and at 1-7 days, 4, 16 and 52 weeks of infant age.
|
|
Parental social risk status as measured by Adverse Childhood Experiences Study Questionnaires (ACES) (Felitti et al., 1998) (trauma, mothers only), work status and level of education
Time Frame: at baseline before birth of the infant
|
ACES is a 25-item self report measure that assesses exposure to childhood emotional, physical, or sexual abuse, and household dysfunction during childhood.
|
at baseline before birth of the infant
|
|
Maternal stress-exposure and stress-sensitivity measured by hair and saliva cortisol
Time Frame: During pregnancy and at infant 16 and 52 weeks of age
|
During pregnancy and at infant 16 and 52 weeks of age
|
|
|
Parental attachment assessed by The Adult Attachment Interview (AAI, George, Kaplan & Main, 1987) (mothers only), The Adult Attachment Projective (AAP, George & West, 2012) and Psychosis Attachment Measure (PAM, Berry, Wearden & Barrowclough, 2006)
Time Frame: At baseline before birth of the infant
|
AAI is a semi-structured interview, consisting of 20 questions and probes, allowing categorisation of an adult individual's state of mind with regard to attachment.
(i.e.
Secure, Dismissing and Preoccupied, Unresolved and Cannot Classify) The Adult Attachment Projective (AAP, George & West, 2012) consists of eight drawings of attachment situations dealing with illness, solitude, separation, loss, and abuse, along with one neutral scene, A narrative depiction of these drawings is transcribed and coded for attachment representation i.e.. secure, dismissing, preoccupied, or unresolved.
PAM, is a self- report questionnaire assessing two dimensions of attachment, anxious and avoidant.
|
At baseline before birth of the infant
|
|
Parental caregiving representation as assessed by Prenatal Care-giving Experiences Questionnaire (PCEQ, Brennan, George, & Solomon, 2013) Care-giving Experiences Questionnaire (CEQ, Brennan, George & Solomon, 2013)
Time Frame: at baseline (PCEQ), 1-7 days, 4,16 and 52 weeks (CEQ)
|
PCEQ, and CEQ assesses defensive processing associated with patterns of care-giving representation (George & Solomon, 2008).
i.e. flexible integration, deactivation, cognitive disconnection and dimension of care-giving dysregulation as related to infant's secure, avoidant, ambivalent-resistant/dependent and disorganised attachment respectively.
|
at baseline (PCEQ), 1-7 days, 4,16 and 52 weeks (CEQ)
|
|
Maternal caregiving behavior as assessed by AMBIANCE (Lyons-Ruth, Bronfmann, & Parson, (1999). Coding Interactive Behavior, CIB (Ruth Feldman, 2012)
Time Frame: 1-7 days, 4 weeks (CIB), 16 and 52 weeks (AMBIANCE)
|
The AMBIANCE measure is used to code disrupted caregiver behaviour during videotaped caregiver-infant interactions.
The five dimensions of the AMBIANCE coding are: affective communication errors, role/boundary confusion, fearful/disorientation, intrusive/negative, and withdrawing behaviour.
CIB is a global measure that looks at parent-child and dyadic affective states and interactive styles.
Independent behavioral codes are aggregated into eight higher order constructs: The three adult constructs are sensitivity, intrusiveness, and limit-setting.
|
1-7 days, 4 weeks (CIB), 16 and 52 weeks (AMBIANCE)
|
|
Paternal caregiving behavior as assessed by CIB
Time Frame: 16 weeks
|
CIB is a global measure that looks at parent-child and dyadic affective states and interactive styles.
Independent behavioral codes are aggregated into eight higher order constructs: The three adult constructs are sensitivity, intrusiveness, and limit-setting.
|
16 weeks
|
|
Paternal symptom severity as assessed by Brief Symptom Severity (BSI-53,Derogatis & Melisaratos, 1983)
Time Frame: At baseline before birth of the infant
|
BSI-53 is a 53 item self-report inventory.
|
At baseline before birth of the infant
|
|
Parental diagnosis as assessed by Structured Clinical Interview for DSM-5 (SCID) psychosis module (mothers). Structured Assessment of Personality Abbreviated Scale (SAPAS, Moran et al 2003)
Time Frame: At baseline before birth of the infant
|
SAPAS is an eight-item screening interview for personality disorder.
|
At baseline before birth of the infant
|
|
Cognitive functioning as assessed by Reynolds Intellectual Screening Test (RIST, Reynolds, Kamphaus and Raines, 2012)
Time Frame: At baseline before birth of the infant
|
RIST is a screening measure of general intelligence
|
At baseline before birth of the infant
|
|
Social functioning and support as assessed by Global Assessment of Functioning, GAF(DSM-IV). Significant Other Scale (SOS, Power, Chanpion & Aris)
Time Frame: At baseline and 4, 16 and 52 weeks
|
SOS determines two main areas of social support, emotional support and practical support.
|
At baseline and 4, 16 and 52 weeks
|
|
Perceived stress as assessed by The Perceived Stress Scale (PSS)
Time Frame: At baseline and at 16 and 52 weeks
|
Questions evaluate experiences of life being unpredictable, uncontrollable and distressing during the previous 30 days, and whether the respondent has been feeling nervous or stressed.
|
At baseline and at 16 and 52 weeks
|
|
Parenting Stress Index, 3rd Edition Short Form (PSI/SF)
Time Frame: At 16 weeks
|
Questions assess level of stress related to the parental role
|
At 16 weeks
|
|
Parental Alliance Measure
Time Frame: At 16 weeks
|
Questions assess the parenting aspects of the marital relationship.
|
At 16 weeks
|
|
ASQ-SE
Time Frame: 52 weeks
|
Ages And Stages Questionnaire Social-Emotional
|
52 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Susanne Harder, PhD, Department of Psychology, University of Copenhagen, Denmark
- Principal Investigator: Andrew Gumley, PhD, University of Glasgow
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
August 1, 2020
Study Completion (Actual)
September 1, 2021
Study Registration Dates
First Submitted
November 12, 2014
First Submitted That Met QC Criteria
November 28, 2014
First Posted (Estimate)
December 3, 2014
Study Record Updates
Last Update Posted (Estimate)
January 24, 2023
Last Update Submitted That Met QC Criteria
January 20, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DFF-1319-00103
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
Sheba Medical CenterNot yet recruiting
-
ACADIA Pharmaceuticals Inc.RecruitingACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response (NORLIGHT)Depressive Disorder, Treatment-Resistant | Major Depressive Disorder (MDD)United States
-
Rotman Research Institute at BaycrestRecruitingMajor Depressive Disorder (MDD)Canada
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingDepression - Major Depressive Disorder | Depression Chronic | Treatment-Resistant Major Depressive Disorder | Depression DisorderSpain
-
Second Affiliated Hospital of Tsinghua UniversityNot yet recruiting
-
First People's Hospital of HangzhouNot yet recruitingMajor Depressive Disorder
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
Shandong Provincial HospitalShandong UniversityRecruiting
-
Engrail Therapeutics INCCompletedMajor Depressive DisorderUnited Kingdom
Clinical Trials on Biological and psycho-social risk and resilience factors
-
Nantes University HospitalCompleted
-
International Centre for Diarrhoeal Disease Research...Recruiting
-
International Centre for Diarrhoeal Disease Research...Completed
-
National Geriatric HospitalCompletedDementia | Alzheimer Disease | Dementia, MixedVietnam
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Fondation Mederic Alzheimer; Direction...CompletedAlzheimer DiseaseFrance
-
Ottawa Hospital Research InstituteCanadian Virtual HospiceTerminatedSevere Grief ReactionCanada
-
Psychiatric Research Unit, Region Zealand, DenmarkCompletedPsychiatric RehabilitationDenmark
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknownHIV Infections | AIDSBrazil
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI); Norris Cotton Cancer CenterCompleted